MARKET

ABP

ABP

ABPRO HLDGS INC
NASDAQ
0.6210
-0.1140
-15.51%
Opening 15:06 02/17 EST
OPEN
0.7500
PREV CLOSE
0.7350
HIGH
0.7575
LOW
0.6067
VOLUME
381.53K
TURNOVER
--
52 WEEK HIGH
34.65
52 WEEK LOW
0.6067
MARKET CAP
1.69M
P/E (TTM)
-0.0255
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ABP last week (0209-0213)?
Weekly Report · 1d ago
Is Abpro Holdings Inc Gaining or Losing Market Support?
Benzinga · 5d ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 5d ago
Why Fastly Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket
Benzinga · 5d ago
Abpro Adds Independent Directors to Address Nasdaq Compliance
TipRanks · 6d ago
Nasdaq Warns Abpro Holdings of Possible Delisting Over Board Compliance Lapses
Reuters · 6d ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 6d ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 6d ago
More
About ABP
Abpro Holdings, Inc. is a biotechnology company. The Company is advancing a pipeline of next generation antibody therapies for human epidermal growth factor receptor 2 (HER2)+cancers, non-HER2+ gastric and liver cancer, and wet age-related macular degeneration and diabetic macular edema. These antibodies are developed using the Company’s proprietary DiversImmune platform. Its two lead product candidates, ABP-102 and ABP-201, feature its next generation tetravalent antibody format (TetraBi antibody format), which binds to two different targets with two distinct binding sites per target. ABP-102 is designed to redirect a patient’s immune system to fight cancer by engaging T cells through co-targeting HER2, and CD3, T-cell co-receptor. ABP-201 is designed to block blood vessel formation and normalize damaged vessels through co-targeting VEGF and ANG-2. It plans to develop ABP-201 to treat vascular disease of the eye, focusing on wet age-related macular degeneration (Wet AMD).

Webull offers ABPRO Holdings Inc stock information, including NASDAQ: ABP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ABP stock methods without spending real money on the virtual paper trading platform.